At a glance
We’re excited to connect with you at the 2026 ESMO Congress.
Meet the Veracyte team and learn how our molecular tests provide personalized insights that support clinicians and patients across breast, prostate, and bladder cancers.
Featured Presentation
Transcriptome classifier risk stratification and intensification with androgen receptor pathway inhibitors (ARPI) for clinically high risk prostate cancer
Saturday, October 24 | 10:15 – 11:45 AM CEST
Oral | Abstract #2045O – Barcelona Auditorium – Hall 9
Prosigna: Featured Presentations & Posters
| Title | Session | Abstract | Date | Time | Author(s) / Speakers | Location | Technology | Schedule |
|---|
Within-trial economic analysis of chemotherapy for high-risk early breast cancer informed by a 50-gene assay: 2-year results from the OPTIMA randomised trial | Proffered Paper | Abstract #LBA869 | Sunday, October 25 | 10:15 – 11:45 AM CET | Peter S. Hall, M.B.Ch.B., M.R.C.P., Ph.D. | Seville Auditorium – NCC | Prosigna Breast Risk of Recurrence Test | |
Decipher: Featured Presentations & Posters
| Title | Session | Abstract | Date | Time | Author(s) / Speakers | Location | Technology | Schedule |
|---|
Prognostic Value of the Decipher Prostate Genomic Classifier (GC) and Neuroendocrine (NE) Gene Expression Signatures in Real-World De Novo Metastatic (M1) Prostate Cancer | Poster | Abstract #4465P | Friday,
October 23 | 3:15 – 4:00 PM CEST | Alice Bernard-Tessier, M.D. | Hall 5 | Decipher Prostate Genomic Classifier | |
Age at Diagnosis as an Independent Prognostic Factor in Urothelial Carcinoma: Impact on Survival and Immune Microenvironment Within Molecular Subtypes | Poster | Abstract #4746P | Friday,
October 23 | 3:15 – 4:00 PM CEST | Michela Piacentini, M.D. | Hall 5 | Decipher Bladder Genomic Classifier | |
Transcriptomic Subtypes Improve AUA risk stratification for Progression after Intravesical Bacillus Calmette Guérin Treatment in Non-muscle Invasive Bladder Cancer Patients | Poster | Abstract #4321P | Friday,
October 23 | 3:15 – 4:00 PM CEST | Mark Farha, M.D. | Hall 5 | Decipher Bladder Genomic Classifier | |
Transcriptome classifier risk stratification and intensification with androgen receptor pathway inhibitors (ARPI) for clinically high risk prostate cancer | Oral | Abstract #2045O | Saturday,
October 24 | 10:15 – 11:45 AM CEST | Sarah Howlett, M.B.B.S. | Barcelona Auditorium –
Hall 9 | Decipher Prostate Genomic Classifier | |
Evaluating the prognostic utility of a genomic classifier (GC) in an Asian real-world cohort of localized prostate cancer (PCa) | ePoster | Abstract #2061eP | Friday, October 23 onwards | 8:00 AM CEST onwards | Melvin Lee Kiang Chua, M.B.B.S., F.R.C.R., Ph.D. | Hall 5 and the ESMO 2026 Virtual Congress Platform | Decipher Prostate Genomic Classifier | |
A Scar-like Transcriptomic Classifier Confirms Favorable Outcomes in Patients with Residual Bladder Cancer (BC) after Perioperative Chemo-immunotherapy | ePoster | Abstract #4521eP | Friday, October 23 onwards | 8:00 AM CEST onwards | Chiara Mercinelli, M.D. | Hall 5 and the ESMO 2026 Virtual Congress Platform | Decipher Bladder GRID | |
Meet with us
Interested in connecting with our team at this event? We’d love to hear from you.
Tags
Europe
Decipher Bladder
Decipher Bladder GRID
Decipher Prostate
Decipher Prostate GRID
Prosigna Breast